Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Oramed Pharmaceuticals Inc., 3 years.
Oramed Pharmaceuticals Inc.
Director
Dave Inc.
Director
Core Scientific Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 15, 2024 | Core Scientific Inc. | Open-market purchase | +80,000 | $3.07 | $245,600 |
| Mar 7, 2024 | Dave Inc. | Open-market purchase | +800 | $37.31 | $29,848 |
| Jan 4, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
| Jan 4, 2024 | Oramed Pharmaceuticals Inc. | Grant or award | +8,820 | — | — |
| Dec 4, 2023 | Dave Inc. | Open-market purchase | +12,941 | $6.40 | $82,822 |
| Jul 6, 2023 | Dave Inc. | Grant or award | +30,239 | — | — |
| Apr 17, 2023 | Oramed Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
| Mar 14, 2023 | Oramed Pharmaceuticals Inc. | Open-market purchase | +50,000 | $2.05 | $102,500 |
| Mar 13, 2023 | Oramed Pharmaceuticals Inc. | Open-market purchase | +20,000 | $1.96 | $39,200 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.